© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Hong Kong SAR

  • HK bans Leissner for life over 1MDB scandal – BofA names new Apac IB co-head – CS nabs equity research head – Nomura loses senior Malaysia banker – New appointments at Goldman
  • Swedish car manufacturer Volvo made its debut in Hong Kong dollars on Wednesday amid increasing tensions and unrest in the city.
  • The Hong Kong securities watchdog has banned former Goldman Sachs banker Tim Leissner from working in the city’s financial industry ever again for his involvement in the 1MDB multi-billion-dollar money laundering scheme.
  • Credit Suisse has poached UBS research veteran Erica Poon Werkun to head equity research for Asia Pacific, according to an internal memo seen by GlobalCapital Asia.
  • China’s Edvantage Group opened books for a HK$805m ($103m) float on the Hong Kong Stock Exchange (HKEX) on Wednesday.
  • Bank of America has appointed former Asia capital markets head Peter Guenthardt as co-head of Asia Pacific investment banking, according to an internal memo seen by GlobalCapital Asia.
  • Hutchison Healthcare Holdings has taken home $288m from an enlarged sell-down of shares in Hutchison China MediTech (Chi-Med).
  • Budweiser Brewing Company Apac has kicked off the roadshow for its up to HK$76.4bn ($9.8bn) Hong Kong listing, on track to be the city’s largest IPO in nearly a decade and the world’s biggest flotation so far this year.
  • Chinese private higher education provider Edvantge is planning to raise up to $100m from a listing on the Hong Kong Stock Exchange, with bookbuilding set to open on Wednesday.
  • China’s Jinshang Bank kicked off its HK$3.42bn ($438m) Hong Kong IPO on strong footing on Friday, with the book well covered ahead of launch.
  • Three new companies have set their sights on listing in Hong Kong, filing draft IPO documents with the exchange.
  • CK Hutchison Holdings is paring down its stake in Hutchison China MediTech (Chi-Med) through a placement after the biopharmaceutical company put its planned Hong Kong IPO on the back burner.